The inaugural AACR Pediatric Cancer Progress Report details advances in treating children and adolescents with cancer and remaining gaps...
Shawn Lee, MD, PhD, an AACR-St. Baldrick’s Foundation Grantee, is working to personalize therapies for children with acute lymphoblastic...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations...
New research highlights approaches that could provide better long-term quality of life for childhood cancer survivors into adulthood.
New clinical trials are exploring an array of CAR T-cell approaches for children with cancers of the brain and...
New AI-driven models unveiled at the AACR Annual Meeting 2025 could revolutionize how we diagnose sarcomas in children.
September is Childhood Cancer Awareness Month. Childhood cancer is relatively rare, but it is a devastating diagnosis that can...
Pediatric cancer, while rare, is the leading cause of death by disease among children past infancy in the developed world. The World Health Organization notes...
Pediatric cancer, while rare, is a devastating diagnosis that is estimated to affect over 11,000 children in the United...